| Sign In to gain access to subscriptions and/or personal tools. |
HIV Progression and Predictors of Mortality in a Community-Based Cohort of Zambian AdultsDepartment of Medicine, University Teaching Hospital, Lusaka, Zambia, HIV Unit, Department of Dermatology and Venerology, Medical University Innsbruck, Austria, maria.kitchen{at}uki.ac.at
Department of Infectious and Tropical Diseases, London School of Hygiene and Topical Medicine, London, United Kingdom
Department of Medicine, University Teaching Hospital, Lusaka, Zambia
Division of Biological Chemistry, Biocentre, Innsbruck Medical University, and Ludwig Boltzmann Institute of AIDS Research, Innsbruck, Austria
Department of Epidemiology Research and Danish Epidemiology Science Center, Statens Seruminstitut, Denmark
Department of Infectious and Tropical Diseases, London School of Hygiene and Topical Medicine, London, United Kingdom
Infectious Diseases Institute, Makerere University, Kampala, Uganda
Department of Infectious and Tropical Diseases, London School of Hygiene and Topical Medicine, London, United Kingdom
This article describes immunological HIV progression, mortality, and its predictors in 974 Zambian adults. During 3138 person-years of follow-up, 281 deaths occurred, and the overall mortality rate was 9.0 per 100 person-years. Thirty-six percent of patients were dead within 5 years of enrollment. The median survival in patients with baseline CD4 count
Key Words: Africa HIV progression mortality CD4 count anemia neopterin gender
This version was published on February
1, 2008 Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 7, No. 1,
17-26 (2008) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
500 cells/mm3 was 5.62 years, with CD4 count between 200 and 499 cells/mm3 5.46 years, and with CD4 count <200 cells/mm3 3.89 years. The mortality rate increased significantly with older age (6.9 in patients <25 years, 9.3 in individuals aged 25-39 years, 10.2 in patients